Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05103098
Other study ID # aswu/354/9/19
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 1, 2021
Est. completion date March 31, 2023

Study information

Verified date October 2021
Source Aswan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this work is to compare the effectiveness of sublingual misoprostol 400 mcg versus 800 mcg for medical treatment of the first trimester missed miscarriage.


Description:

the study will be made on female patients with the first trimester missed abortion confirmed by ultrasound. Participants will be divided into 2 groups one group (A) will receive sublingual Misoprostol 400 mcg and the other group(B) will receive sublingual Misoprostol 800 mcg every 4 hours in both groups up to 3 doses the aim of the study is to compare the efficacy of sublingual Misoprostol in complete termination of the first trimester missed abortion and which route is the best will less side effects.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date March 31, 2023
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - All women above 18 years of age - Less than 12 weeks of gestation. - Pregnancy is confirmed by pregnancy test or ultrasound scan. - missed abortion - Normal general and gynecological examination. Exclusion Criteria: - Hemodynamically unstable. - Suspected sepsis with temperature 38 °C. - Concurrent medical illness e.g. hematological, cardiovascular, thromboembolism, - respiratory illnesses, recent liver disease, or pruritus of pregnancy. - Presence of intrauterine contraceptive device (IUCD). - Suspect or proven ectopic pregnancy. - Failed medical or surgical evacuation before the presentation. - Known allergy to misoprostol.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
misoprostol 400 mcg
All patients will receive three doses of sublingual misoprostol every four hours The first dose of misoprostol 400 mcg will be administrated at the hospital. Then the patient will be observed for 1 hour for any immediate adverse reaction Clear instructions about the method and timing of the second dose will be given upon sending home. Two doses of misoprostol 400 mcg each (four tablets of 200 mcg per dose). Paracetamol, eight hourly, will be provided as an analgesic or antipyretic. A specimen bottle to collect the POC if passed out. Two pairs of disposable gloves. Pre-filled histopathological examination form to be sent to the laboratory together with the products of conception
misoprostol 800 mcg
All patients will receive three doses of sublingual misoprostol every four hours The first dose of misoprostol 800 mcg will be administrated at the hospital. Then the patient will be observed for 1 hour for any immediate adverse reaction Clear instructions about the method and timing of the second dose will be given upon sending home. Two doses of misoprostol 800 mcg each (four tablets of 200 mcg per dose). Paracetamol, eight hourly, will be provided as an analgesic or antipyretic. A specimen bottle to collect the POC if passed out. Two pairs of disposable gloves. Pre-filled histopathological examination form to be sent to the laboratory together with the products of conception

Locations

Country Name City State
Egypt Aswan University Hospital Aswan

Sponsors (1)

Lead Sponsor Collaborator
hany farouk

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Completeness of abortion Number of Participants with expulsion of Products of conception by visual inspection 7 days
Secondary Successful medical abortion Number of Participants with cervical os is closed with endometrial thickness of less than 15 mm 7 days
Secondary amount of calculated blood loss following treatment amount of calculated blood loss 7 days
See also
  Status Clinical Trial Phase
Recruiting NCT05969574 - Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?
Enrolling by invitation NCT01689428 - Ism1 Versus EmbryoGen Media for Embryo Culture in Previous Pregnancy Loss Cases Phase 3
Completed NCT00194844 - Couples Miscarriage Healing Project:Randomized Trial Phase 1/Phase 2
Recruiting NCT05789940 - Hysteroscopy vs. Endouterine Aspiration in the Management of Trophoblastic Retention N/A
Recruiting NCT03628625 - Letrozole Pretreatment With Misoprostol fInduction of Abortion In First-Trimester Missed Miscarriage Phase 2
Not yet recruiting NCT05557201 - Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors
Not yet recruiting NCT05579756 - Psychatric Impact of Miscarriage in Assiut University Hospital
Not yet recruiting NCT05039853 - Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task N/A
Recruiting NCT01223482 - A Study Looking at Women's Experiences After a Miscarriage N/A
Completed NCT04604366 - Comparison of Vaginal Versus Sublingual Misoprostol in the Treatment of First Trimester Missed Miscarriage Phase 2
Not yet recruiting NCT05088707 - Sublingual Versus Vaginal Misoprostol In Medical Treatment of Second Trimestric Missed Miscarriage N/A
Not yet recruiting NCT05094375 - Vaginal Misoprostol In Medical Treatment of First Trimester Missed Miscarriage N/A
Not yet recruiting NCT05088720 - Misoprostol for Management of Women With an Incomplete Miscarriage N/A
Recruiting NCT05304273 - Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages Phase 3
Not yet recruiting NCT05653414 - Interest of a Short Early Psychological Care in Women With Miscarriage N/A
Recruiting NCT03976544 - Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients Phase 4
Completed NCT01916928 - The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage N/A
Completed NCT03940495 - Serum Kisspeptin: a Predictive Marker of Miscarriage or Not?
Completed NCT04512820 - Treatment of Missed Miscarriage With TRUCLEAR Tissue Removal System, a Feasiblity Study N/A
Recruiting NCT05762770 - A Trial of Sperm Injection (PICSI) on Miscarriage Rates in Assisted Conception N/A